Stock Analiz

Ovid Therapeutics Inc. (OVID) stock forecast and price target

Price $2.54 · data as of November 13, 2026

12-month price target

Average target$6.15
Upside / downside+142.1%
Analysts10
ConsensusStrong buy
Low $4.00Average $6.15High $9.00

Gold marker: average target · white marker: today’s price ($2.54)

Analyst ratings

Strong buy 0Buy 13Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.40−73.9%$810500
Next fiscal year
ends December 31, 2027
$-0.40−1.1%$258420
Next quarter
ends December 31, 2026
$-0.08−240.7%$66250
Quarter after
ends December 31, 2026
$-0.10−270.8%$16670

Consensus of the analysts covering Ovid Therapeutics, updated daily. In the last 30 days 7 estimates were raised and 0 lowered.

Frequently asked questions

What is the Ovid Therapeutics stock price target?

The average 12-month target from 10 analysts is $6.15, 142.1% above the current price of $2.54 Targets range from $4.00 to $9.00.

Is Ovid Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (13 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Ovid Therapeutics expected to earn?

Analysts expect EPS of $-0.40 for the fiscal year ending December 31, 2026 and $-0.40 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.